Literature DB >> 26672347

[Simulation and Prediction of Material Foundation of Rhei Radix et Rhizoma for Ischemic Stroke Based on Molecular Docking Technology].

Li Lu, Qin-xiao Guan, Yuan-xin Tian, Jie-xin Lin, Sheng-wang Liang, Shu-mei Wang.   

Abstract

OBJECTIVE: To apply molecular docking technology for virtual screening of active molecules of Rhei Radix et Rhizoma, and to explore the effective substances.
METHODS: 21 key targets proteins related with cerebral ischemia with 52 compounds of Rhei Radix et Rhizoma based on molecular docking technology were combined to select active small molecules. Meanwhile, multi-component protein target network was established by software Cytoscape 2. 8. 1.
RESULTS: It was identified that 23 of those compounds had strong interactions with no less than 10 targets by virtual screening of molecular docking.
CONCLUSION: The method of virtual screening based on molecular docking can be used to find the active components of Rhei Radix et Rhizoma in treatment of cerebral ischemia. It provides the reference for research on multi-targets of Chinese medicine compound.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26672347

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  3 in total

1.  Network pharmacology and in vitro experimental verification to explore the mechanism of Sanhua decoction in the treatment of ischaemic stroke.

Authors:  Wei Zhang; Li Zhang; Wen Jun Wang; Shanbo Ma; Mingming Wang; Minna Yao; Ruili Li; Wei Wei Li; Xian Zhao; Dongmei Hu; Yi Ding; Jingwen Wang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

2.  Comparison of Three Species of Rhubarb in Inhibiting Vascular Endothelial Injury via Regulation of PI3K/AKT/NF-κB Signaling Pathway.

Authors:  Xin Li; Songli Huang; Bingyu Zhuo; Jingyan Hu; Yue Shi; Jiangyi Zhao; Jincheng Tang; Xiuhua Hu; Shengli Wei
Journal:  Oxid Med Cell Longev       Date:  2022-03-28       Impact factor: 7.310

3.  Adjuvant Chinese Herbal Products for Preventing Ischemic Stroke in Patients with Atrial Fibrillation.

Authors:  Yu-Chiang Hung; Yu-Chen Cheng; Chih-Hsin Muo; Hsienhsueh Elley Chiu; Chun-Ting Liu; Wen-Long Hu
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.